Synthesis and in vitro characterization of a P2X7 radioligand [123I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease

Jin, Hongjun; Han, Junbin; Resing, Derek; Liu, Hui; Yue, Xuyi; Miller, Rebecca L.; Schoch, Kathleen M.; Miller, Timothy M.; Perlmutter, Joel S.; Egan, Terrance M.; Tu, Zhude

doi:10.1016/j.ejphar.2017.12.006

Title: Synthesis and in vitro characterization of a P2X7 radioligand [123I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease

Full Record
Other Related Research

Authors:: Jin, Hongjun; Han, Junbin; Resing, Derek; Liu, Hui; Yue, Xuyi; Miller, Rebecca L.; Schoch, Kathleen M.; Miller, Timothy M.; Perlmutter, Joel S.; Egan, Terrance M.; Tu, Zhude

Publication Date:: 2018-02-01

Sponsoring Org.:: USDOE

OSTI Identifier:: 1495263

Grant/Contract Number:: DESC0008432; DESC0012737

Resource Type:: Publisher's Accepted Manuscript

Journal Name:: European Journal of Pharmacology

Additional Journal Information:: Journal Name: European Journal of Pharmacology Journal Volume: 820 Journal Issue: C; Journal ID: ISSN 0014-2999

Publisher:: Elsevier

Country of Publication:: Netherlands

Language:: English

Citation Formats


                    Jin, Hongjun, Han, Junbin, Resing, Derek, Liu, Hui, Yue, Xuyi, Miller, Rebecca L., Schoch, Kathleen M., Miller, Timothy M., Perlmutter, Joel S., Egan, Terrance M., and Tu, Zhude. Synthesis and in vitro characterization of a P2X7 radioligand [123I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease.  Netherlands: N. p., 2018. 
Web.  doi:10.1016/j.ejphar.2017.12.006.

Copy to clipboard


                    Jin, Hongjun, Han, Junbin, Resing, Derek, Liu, Hui, Yue, Xuyi, Miller, Rebecca L., Schoch, Kathleen M., Miller, Timothy M., Perlmutter, Joel S., Egan, Terrance M., & Tu, Zhude. Synthesis and in vitro characterization of a P2X7 radioligand [123I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease.  Netherlands.  https://doi.org/10.1016/j.ejphar.2017.12.006

Copy to clipboard


                    Jin, Hongjun, Han, Junbin, Resing, Derek, Liu, Hui, Yue, Xuyi, Miller, Rebecca L., Schoch, Kathleen M., Miller, Timothy M., Perlmutter, Joel S., Egan, Terrance M., and Tu, Zhude. Thu .  
"Synthesis and in vitro characterization of a P2X7 radioligand [123I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease".  Netherlands.  https://doi.org/10.1016/j.ejphar.2017.12.006.

Copy to clipboard


                    
@article{osti_1495263,

  title        = {Synthesis and in vitro characterization of a P2X7 radioligand [123I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease},

  author       = {Jin, Hongjun and Han, Junbin and Resing, Derek and Liu, Hui and Yue, Xuyi and Miller, Rebecca L. and Schoch, Kathleen M. and Miller, Timothy M. and Perlmutter, Joel S. and Egan, Terrance M. and Tu, Zhude},

  abstractNote = {},

  doi          = {10.1016/j.ejphar.2017.12.006},

  journal      = {European Journal of Pharmacology},

  number       = C,

  volume       = 820,

  place        = {Netherlands},

  year         = {2018},

  month        = {2}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (Publisher)

Publisher's Version of Record
https://doi.org/10.1016/j.ejphar.2017.12.006

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 26 works

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

Synthesis and in vitro characterization of a P2X7 radioligand [123I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease

Journal Article Jin, Hongjun ; Han, Junbin ; Resing, Derek ; ... - European Journal of Pharmacology

Not provided.
https://doi.org/10.1016/j.ejphar.2017.12.006
Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease

Journal Article Cai, Hong-Yan ; Yang, Jun-Ting ; Wang, Zhao-Jun ; ... - Biochemical and Biophysical Research Communications

Highlights: • Lixisenatide reduced amyloid plaques, neurofibrillary tangles and neuroinflammation. • Activiation of PKA-CREB and inhibition of p38-MAPK were the protective mechanisms. • Lixisenatide might have the potential to be developed as a novel therapy for AD. Type 2 diabetes mellitus (T2DM) has been identified as a high risk factor for Alzheimer's disease (AD). The impairment of insulin signaling has been found in AD brain. Glucagon-like peptide-1 (GLP-1) is an incretin hormone, normalises insulin signaling and acts as a neuroprotective growth factor. We have previously shown that the long-lasting GLP-1 receptor (GLP-1R) agonist lixisenatide plays an important role in memorymore »« less
https://doi.org/10.1016/J.BBRC.2017.11.114
Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response

Journal Article Han, Junbin ; Liu, Hui ; Liu, Chunling ; ... - Nuclear Medicine Communications

OBJECTIVE: The P2X7 receptor (P2X7R) is a key regulatory element in the neuroinflammatory cascade that provides a promising target for imaging neuroinflammation. GSK1482160, a P2X7R modulator with nanomolar binding affinity and high selectivity, has been successfully radiolabeled and utilized for imaging P2X7 levels in a mouse model of lipopolysaccharide-induced systemic inflammation. In the current study, we further characterized its binding profile and determined whether [¹¹C]GSK1482160 can detect changes in P2X7R expression in a rodent model of multiple sclerosis. METHODS: [¹¹C]GSK1482160 was synthesized with high specific activity and high radiochemical purity. Radioligand saturation and competition binding assays were performed for [¹¹C]GSK1482160more »« less
Cited by 44
https://doi.org/10.1097/MNM.0000000000000660

Full Text Available
Characterization of high specific activity (16 alpha-123I)Iodo-17 beta-estradiol as an estrogen receptor-specific radioligand capable of imaging estrogen receptor-positive tumors

Journal Article Pavlik, E J ; Nelson, K ; Gallion, H H ; ... - Cancer Research; (USA)

16 alpha-(123I)Iodo-17 beta-estradiol (16 alpha-(123I)E2) has been characterized for use as a selective radioligand for estrogen receptor (ERc) that is capable of generating in situ images of ERc-positive tumors. High specific activity 16 alpha-(123I)E2 (7,500-10,000 Ci/mmol) was used in all determinations. Radiochemical purity was determined by thin layer chromatography, and the selectivity of radioligand for ERc was evaluated using size exclusion high performance liquid chromatography on ERc prepared from rodent uteri. Efficiencies of radioidination approaching 100% were achieved, and excellent receptor selectivity was obtained even when the efficiency of radioiodination was as low as 10%. Low radiochemical purity was alwaysmore »« less
Targeting Human Central Nervous System Protein Kinases: An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease Progression in Alzheimer’s Disease Mouse Models

Journal Article Roy, Saktimayee M. ; Grum-Tokars, Valerie L. ; Schavocky, James P. ; ... - ACS Chemical Neuroscience

The first kinase inhibitor drug approval in 2001 initiated a remarkable decade of tyrosine kinase inhibitor drugs for oncology indications, but a void exists for serine/threonine protein kinase inhibitor drugs and central nervous system indications. Stress kinases are of special interest in neurological and neuropsychiatric disorders due to their involvement in synaptic dysfunction and complex disease susceptibility. Clinical and preclinical evidence implicates the stress related kinase p38αMAPK as a potential neurotherapeutic target, but isoform selective p38αMAPK inhibitor candidates are lacking and the mixed kinase inhibitor drugs that are promising in peripheral tissue disease indications have limitations for neurologic indications. Therefore,more »« less
Cited by 53
https://doi.org/10.1021/acschemneuro.5b00002

Full Text Available

Similar Records